Laura Cogrossi
@lauracgr001
Science explorer in Immunology 🔬 PhD Student @Bellone_lab @myunisr @sanraffaelemi
ID: 1285644271270404096
21-07-2020 18:34:22
38 Tweet
50 Followers
169 Following
Exploiting the Gut Microbiota to Boost Immunotherapy and Switch the Trajectory of Multiple Myeloma [Mon, Dec 11, 2023: 11:15a] Laura Cogrossi et al. #ASH23 Abst 754 ash.confex.com/ash/2023/webpr… #IDonc #ImmunoOnc #mmsm
Kicking off the DITID24 retreat: amazing talk by our stellar Laura Cogrossi of CellularImmune_lab outlying how immune microbiote shape the immune sistem in Multiple Myeloma
Most important slide of my presentation at divisional #DITID #retreat in Brescia! As always thank to CellularImmune_lab and happy to share new perspectives going on in our division Ospedale San Raffaele
Great performance for Giovanni Pastorino at his first divisional #DITID Retreat! Interesting fusion between lab and clinic
A paper in Nature Medicine reports on efforts to identify microbial signatures of response to immune checkpoint blockade that suggest that strain-level associations may be cancer type agnostic but cancer therapy specific. go.nature.com/3V2JgLx
Growing evidence shows that dietary interventions can be effective at treating or delaying some diseases, but further trials are needed for wider adoption (especially in cancer) Nature Medicine nature.com/articles/s4159…
New paper out in today Nature Communications! 🎉🎉With Mayo Clinic University of Miami Sylvester Comprehensive Cancer Center Leif Bergsagel, Marta Chesi, Coffey D we integrated #wgs #scrna to show how Vk*MYC Mouse genomic evolution mimics the one observed in human myeloma #mmsm (1/xx) 🧵👇
Let’s fight cancer together Fondazione AIRC per la ricerca sul cancro
Out in Journal of Clinical Oncology our next piece of the neoadjuvant puzzle in muscle-invasive #bladdercancer. Taxanes could be another good choice of backbone chemo to combine with IO, overcoming the known limits of platinum. #NureCombo provided Nivo/ABX x4 > RC > adj Nivo x13. N=31. 22 pts
Novel data finally out on muscle-invasive #bladdercancer #neoadjuvant therapy. Glad to have contributed to #immunebiomarker analysis CellularImmune_lab Andrea Necchi ascopubs.org/doi/10.1200/JC…
Honored to be selected to share our work during #diet and #microbiota session with amazing speakers. #FMT, #microbiota-based therapies and #nutrition the novel pillars for cancer prevention and immunotherapy #Cicon24 Cancer Research Institute
Today’s issue of The Washington Post The Washington Post keeps up with #cicon24 topics! #fibers plant-based #diet. Perfect meeting conclusion just before takeoff
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive #BladderCancer brnw.ch/21wMC1Y Andrea Necchi #blsm